SCHEMBL4778419

SCHEMBL4778419

CC1(C)Nc2cc(/C=C/C(=O)O)cnc2OC1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.42
ALOX5 P09917 1/20 0.39
P4HTM Q9NXG6 1/20 0.37
ESR1 P03372 3/20 0.35
IP6K1 Q92551 5/20 0.33
IP6K3 Q96PC2 5/20 0.33
IP6K2 Q9UHH9 5/20 0.33
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
MET P08581 1/20 0.33
HTT P42858 2/20 0.33
GCK P35557 1/20 0.33
GAA P10253 1/20 0.33
TBK1 Q9UHD2 1/20 0.33
LMNA P02545 1/20 0.33
MITF O75030 1/20 0.32
HPGD P15428 1/20 0.32
KLF5 Q13887 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5275224 1.00 RAB9A (0.42) RAB9AALOX5P4HTMESR1IP6K1
SCHEMBL22010721 0.77 RAB9A (0.41) RAB9AALOX5P4HTMESR1ALDH1A1
Hydrochloric Acid SCHEMBL4777307 0.77 RAB9A (0.41) RAB9AALOX5P4HTMESR1IP6K1
SCHEMBL4771852 0.76 RAB9A (0.46) RAB9AALOX5P4HTMESR1ALDH1A1
SCHEMBL5276342 0.76 RAB9A (0.46) RAB9AALOX5P4HTMESR1ALDH1A1
Trifluoroacetic Acid SCHEMBL21963997 0.74 RAB9A (0.36) RAB9AALOX5P4HTMESR1ALDH1A1
SCHEMBL3888548 0.72 ALDH1A1 (0.44) RAB9AALOX5P4HTMALDH1A1KDM4E
SCHEMBL3888550 0.72 ALDH1A1 (0.44) RAB9AALOX5P4HTMALDH1A1KDM4E
SCHEMBL6219602 0.68 RAB9A (0.45) RAB9AALOX5P4HTMESR1ALDH1A1
SCHEMBL1254770 0.67 BRD4 (0.42) RAB9AALOX5P4HTMALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1973902-A2 3-HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS Affinium Pharmaceuticals, Inc. (CA) 2008-10-01 EP disclosed
WO-2007067416-A2 HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS AFFINIUM PHARMACEUTICALS, INC. (CA) 2007-06-14 WO disclosed